Novartis
Novartis is a global pharmaceutical company that researches, develops, manufactures, and markets innovative prescription medicines across therapeutic areas such as oncology, immunology, cardiovascular, and neuroscience. It serves patients worldwide through branded drugs and generics, selling primarily to healthcare providers, hospitals, pharmacies, and governments. The company generates revenue from the commercialization of patented therapies, licensing, and related healthcare products and services.
- Revenue
- $45.8B
- Employees
- 76,000
- Founded
- 1996
- Headquarters
- Basel, Switzerland
What 18 Arbolus experts think of Novartis
Promoters (NPS 9–10) represent roughly 75% of the pool, with only 2 detractors (NPS 1) and a small number in the passive range (NPS 7–8). Renewal intent is overwhelmingly positive among influencers and high-value accounts, with all high spenders indicating intent to renew. Most customers report using the solution for more than 1 year, indicating high stickiness. Sentiment is strongest among influencers and high spenders in healthcare organizations, while uncertainty is limited to a small minority. Overall Customer Sentiment: Positive
Who reviewed Novartis
- C-Suite 82% (15)
- Director 18% (3)
Employer names and spend open once the report publishes.
Tell us when the Novartis report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
50 Net Promoter Score, from 18 scored reviews- Promoters 11
- Passives 5
- Detractors 2
Cumulative NPS by month
+0 over 6 months- Mar 8
- Apr 8
- May 8
- Jul 8
- Aug 8
- Sep 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 50 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 75%Plan to renew, by seniority
- 71% 7 answers
- 100% 1 answer
- 9.3/10 Average score from customers who will renew
- 4.5/10 Average score from undecided customers
For people who use Novartis
Do you use Novartis at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 18 customers of Novartis have already contributed
Takes a few minutes. Your identity stays anonymous.